RG
Rathbones Group Portfolio holdings
AUM
$23.2B
1-Year Return
20.53%
This Quarter Return
+10.35%
1 Year Return
+20.53%
3 Year Return
+86.31%
5 Year Return
+133.83%
10 Year Return
+465.76%
AUM
$9B
AUM Growth
+$1.19B
(+15%)
Cap. Flow
+$461M
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
32.41%
Holding
435
New
32
Increased
155
Reduced
116
Closed
11
Top Buys
| 1 |
DexCom
DXCM
|
$84.5M |
| 2 |
Intuitive Surgical
ISRG
|
$76.4M |
| 3 |
Monster Beverage
MNST
|
$75.8M |
| 4 |
SBNY
Signature Bank
SBNY
|
$63M |
| 5 |
Morgan Stanley
MS
|
$24.5M |
Top Sells
| 1 |
Nike
NKE
|
$90.9M |
| 2 |
RingCentral
RNG
|
$71M |
| 3 |
Netflix
NFLX
|
$67.2M |
| 4 |
Jack Henry & Associates
JKHY
|
$60.1M |
| 5 |
PTC
PTC
|
$11.1M |
Sector Composition
| 1 | Technology | 22.46% |
| 2 | Financials | 20.13% |
| 3 | Consumer Staples | 11.43% |
| 4 | Healthcare | 11.1% |
| 5 | Consumer Discretionary | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
iShares China Large-Cap ETF
FXI
$6.64B
| $427K | ﹤0.01% |
9,215
-1,110
| -11% | -$51.4K |
|
|
TGI
327
DELISTED
Triumph Group
TGI
| $415K | ﹤0.01% |
20,000
| – | – |
|
328
Sempra
SRE
$52.9B
| $411K | ﹤0.01% |
6,200
| – | – |
|
329
Dow Inc
DOW
$17.1B
| $401K | ﹤0.01% |
6,344
| – | – |
|
|
TRHC
330
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $400K | ﹤0.01% |
7,990
+100
| +1% | +$5.01K |
|
331
Zscaler
ZS
$42B
| $395K | ﹤0.01% |
1,827
| – | – |
|
|
SRNE
332
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $395K | ﹤0.01% |
40,784
-1,700
| -4% | -$16.5K |
|
|
PPTA
333
Perpetua Resources
PPTA
$1.99B
| $390K | ﹤0.01% |
53,200
| – | – |
|
334
NIO
NIO
$13.4B
| $388K | ﹤0.01% |
7,284
-975
| -12% | -$51.9K |
|
335
BioLife Solutions
BLFS
$1.25B
| $386K | ﹤0.01% |
8,668
-350
| -4% | -$15.6K |
|
336
Zoom
ZM
$24.8B
| $380K | ﹤0.01% |
981
-221
| -18% | -$85.6K |
|
337
Charter Communications
CHTR
$35.5B
| $373K | ﹤0.01% |
517
| – | – |
|
338
UnitedHealth
UNH
$287B
| $373K | ﹤0.01% |
931
-60
| -6% | -$24K |
|
339
Wabtec
WAB
$32.8B
| $372K | ﹤0.01% |
4,525
-885
| -16% | -$72.8K |
|
340
HUTCHMED
HCM
$2.73B
| $371K | ﹤0.01% |
9,450
| – | – |
|
341
XPeng
XPEV
$19B
| $369K | ﹤0.01% |
+8,315
| New | +$369K |
|
|
QVCGA
342
QVC Group, Inc. Series A Common Stock
QVCGA
$70.8M
| $367K | ﹤0.01% |
560
+300
| +115% | +$197K |
|
|
SILK
343
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $357K | ﹤0.01% |
7,450
| – | – |
|
|
RDS.A
344
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $357K | ﹤0.01% |
8,845
| – | – |
|
345
Markel Group
MKL
$24.2B
| $354K | ﹤0.01% |
298
| – | – |
|
346
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $347K | ﹤0.01% |
2,000
| – | – |
|
347
American Tower
AMT
$93B
| $344K | ﹤0.01% |
1,272
-250
| -16% | -$67.6K |
|
348
Ares Management
ARES
$38.7B
| $337K | ﹤0.01% |
5,300
| – | – |
|
349
Exelixis
EXEL
$10.1B
| $337K | ﹤0.01% |
18,500
| – | – |
|
350
Viatris
VTRS
$12.2B
| $333K | ﹤0.01% |
23,317
-5,482
| -19% | -$78.3K |
|